EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies

David S Goldstein, Patti Sullivan, Courtney Holmes

Clinical Autonomic Research · 2025-04 · 35 (2) · 215-222

DOI: 10.1007/s10286-024-01093-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Autonomic Research, online erschienen am 10.12.2024. Verfasst von David S Goldstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Autonomic Medicine Section (AMS), Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Dis…. Hauptthemen laut MEDLINE: Norepinephrine, Dopamine, Multiple System Atrophy, Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autonomic synucleinopathies feature autonomic failure and intracellular deposition of the protein alpha-synuclein. Three such conditions are the Lewy body diseases (LBDs) Parkinson’s disease (PD) and pure autonomic failure (PAF) and the non-LBD synucleinopathy multiple system atrophy (MSA). These diseases all entail catecholaminergic abnormalities in the brain, sympathetically innervated organs, or both; however, little is known about renal catecholaminergic functions in autonomic synucleinopathies. We measured urinary excretion rates of the sympathetic neurotransmitter norepinephrine, the hormone epinephrine, the autocrine-paracrine substance dopamine, the catecholamine precursor 3,4-dihydroxyphenylalanine (DOPA), 3,4-dihydroxyphenylglycol (DHPG, the main neuronal metabolite of norepinephrine), and 3,4-dihydroxyphenylacetic acid (DOPAC, a major dopamine metabolite), in PD, PAF, and MSA groups and controls.

Methods

Data were reviewed from all research participants who had urine collections (usually 3.5 h) at the National Institutes of Health (NIH) Clinical Center from 1995 to 2024. The control cohort had neither autonomic failure nor a movement disorder.

Results

Norepinephrine excretion rates were decreased compared with controls in PD ( p = 0.0001), PAF ( p < 0.0001), and MSA ( p < 0.0001). Dopamine excretion was also decreased in the three groups (PD: p = 0.0136, PAF: p = 0.0027, MSA: p = 0.0344). DHPG excretion was decreased in PD ( p = 0.0004) and PAF ( p = 0.0004) but not in MSA. DOPA and epinephrine excretion did not differ among the study groups.

Conclusions

Autonomic synucleinopathies involve decreased urinary excretion rates of norepinephrine and dopamine. Since virtually all of urinary dopamine in humans is derived from circulating DOPA, the low rates of urinary norepinephrine and dopamine excretion may reflect dysfunctions in the renal sympathetic noradrenergic system, the DOPA-dopamine autocrine-paracrine system, or both systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NorepinephrineDopamineMultiple System AtrophyParkinson DiseaseSynucleinopathiesPure Autonomic FailureHumansMaleFemaleAgedMiddle AgedLewy Body Disease

Stichwörter der Autor:innen

AutonomicDopamineKidneyNorepinephrineSynuclein

Substanzen

NorepinephrineDopamine

Autor:innen und Institutionen

  • Autonomic Medicine Section (AMS), Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), 10 Cen…

Förderung

  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Goldstein, D. S., Sullivan, P., & Holmes, C. (2025). Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies. Clinical Autonomic Research, 35(2), 215-222. https://doi.org/10.1007/s10286-024-01093-6

Vancouver

Goldstein DS, Sullivan P, Holmes C. Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies. Clinical Autonomic Research. 2025;35(2):215-222. doi:10.1007/s10286-024-01093-6

BibTeX
@article{Goldstein2025,
  author = {Goldstein, David S and Sullivan, Patti and Holmes, Courtney},
  title = {Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies},
  journal = {Clinical Autonomic Research},
  year = {2025},
  volume = {35},
  number = {2},
  pages = {215--222},
  doi = {10.1007/s10286-024-01093-6}
}
Kostenlos starten →